img

Global Uterine Fibroids Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Uterine Fibroids Treatment Market Research Report 2024

Uterine fibroids are frequently found incidentally during a routine pelvic exam. There's no single best approach to uterine fibroid treatment — many treatment options exist.
According to MRAResearch’s new survey, global Uterine Fibroids Treatment market is projected to reach US$ 182 million in 2033, increasing from US$ 154.8 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Uterine Fibroids Treatment market research.
Key companies engaged in the Uterine Fibroids Treatment industry include Blue Endo, Boston Scientific Corporation, Cooper Surgical, Acessa Health, Inc., Karl Storz, LiNA Medical, Merit Medical Systems and Olympus Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Uterine Fibroids Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Uterine Fibroids Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Uterine Fibroids Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Blue Endo
Boston Scientific Corporation
Cooper Surgical
Acessa Health, Inc.
Karl Storz
LiNA Medical
Merit Medical Systems
Olympus Corporation
Segment by Type
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Uterine Fibroids Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Fibroids Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Endometrial Ablation
1.2.3 MRI Guided Procedures
1.2.4 Hysterectomy
1.2.5 Myomectomy
1.2.6 Uterine Artery Embolization
1.2.7 Radiofrequency Ablation
1.2.8 Others
1.3 Market by Application
1.3.1 Global Uterine Fibroids Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Uterine Fibroids Treatment Market Perspective (2018-2033)
2.2 Uterine Fibroids Treatment Growth Trends by Region
2.2.1 Global Uterine Fibroids Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Uterine Fibroids Treatment Historic Market Size by Region (2018-2023)
2.2.3 Uterine Fibroids Treatment Forecasted Market Size by Region (2024-2033)
2.3 Uterine Fibroids Treatment Market Dynamics
2.3.1 Uterine Fibroids Treatment Industry Trends
2.3.2 Uterine Fibroids Treatment Market Drivers
2.3.3 Uterine Fibroids Treatment Market Challenges
2.3.4 Uterine Fibroids Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Uterine Fibroids Treatment Players by Revenue
3.1.1 Global Top Uterine Fibroids Treatment Players by Revenue (2018-2023)
3.1.2 Global Uterine Fibroids Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Uterine Fibroids Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroids Treatment Revenue
3.4 Global Uterine Fibroids Treatment Market Concentration Ratio
3.4.1 Global Uterine Fibroids Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroids Treatment Revenue in 2022
3.5 Uterine Fibroids Treatment Key Players Head office and Area Served
3.6 Key Players Uterine Fibroids Treatment Product Solution and Service
3.7 Date of Enter into Uterine Fibroids Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Uterine Fibroids Treatment Breakdown Data by Type
4.1 Global Uterine Fibroids Treatment Historic Market Size by Type (2018-2023)
4.2 Global Uterine Fibroids Treatment Forecasted Market Size by Type (2024-2033)
5 Uterine Fibroids Treatment Breakdown Data by Application
5.1 Global Uterine Fibroids Treatment Historic Market Size by Application (2018-2023)
5.2 Global Uterine Fibroids Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Uterine Fibroids Treatment Market Size (2018-2033)
6.2 North America Uterine Fibroids Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Uterine Fibroids Treatment Market Size by Country (2018-2023)
6.4 North America Uterine Fibroids Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Uterine Fibroids Treatment Market Size (2018-2033)
7.2 Europe Uterine Fibroids Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Uterine Fibroids Treatment Market Size by Country (2018-2023)
7.4 Europe Uterine Fibroids Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Uterine Fibroids Treatment Market Size (2018-2033)
8.2 Asia-Pacific Uterine Fibroids Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Uterine Fibroids Treatment Market Size (2018-2033)
9.2 Latin America Uterine Fibroids Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Uterine Fibroids Treatment Market Size by Country (2018-2023)
9.4 Latin America Uterine Fibroids Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Uterine Fibroids Treatment Market Size (2018-2033)
10.2 Middle East & Africa Uterine Fibroids Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Blue Endo
11.1.1 Blue Endo Company Detail
11.1.2 Blue Endo Business Overview
11.1.3 Blue Endo Uterine Fibroids Treatment Introduction
11.1.4 Blue Endo Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.1.5 Blue Endo Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Detail
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Uterine Fibroids Treatment Introduction
11.2.4 Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Cooper Surgical
11.3.1 Cooper Surgical Company Detail
11.3.2 Cooper Surgical Business Overview
11.3.3 Cooper Surgical Uterine Fibroids Treatment Introduction
11.3.4 Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.3.5 Cooper Surgical Recent Development
11.4 Acessa Health, Inc.
11.4.1 Acessa Health, Inc. Company Detail
11.4.2 Acessa Health, Inc. Business Overview
11.4.3 Acessa Health, Inc. Uterine Fibroids Treatment Introduction
11.4.4 Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.4.5 Acessa Health, Inc. Recent Development
11.5 Karl Storz
11.5.1 Karl Storz Company Detail
11.5.2 Karl Storz Business Overview
11.5.3 Karl Storz Uterine Fibroids Treatment Introduction
11.5.4 Karl Storz Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.5.5 Karl Storz Recent Development
11.6 LiNA Medical
11.6.1 LiNA Medical Company Detail
11.6.2 LiNA Medical Business Overview
11.6.3 LiNA Medical Uterine Fibroids Treatment Introduction
11.6.4 LiNA Medical Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.6.5 LiNA Medical Recent Development
11.7 Merit Medical Systems
11.7.1 Merit Medical Systems Company Detail
11.7.2 Merit Medical Systems Business Overview
11.7.3 Merit Medical Systems Uterine Fibroids Treatment Introduction
11.7.4 Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.7.5 Merit Medical Systems Recent Development
11.8 Olympus Corporation
11.8.1 Olympus Corporation Company Detail
11.8.2 Olympus Corporation Business Overview
11.8.3 Olympus Corporation Uterine Fibroids Treatment Introduction
11.8.4 Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2018-2023)
11.8.5 Olympus Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Uterine Fibroids Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Endometrial Ablation
Table 3. Key Players of MRI Guided Procedures
Table 4. Key Players of Hysterectomy
Table 5. Key Players of Myomectomy
Table 6. Key Players of Uterine Artery Embolization
Table 7. Key Players of Radiofrequency Ablation
Table 8. Key Players of Others
Table 9. Global Uterine Fibroids Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Uterine Fibroids Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Uterine Fibroids Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Uterine Fibroids Treatment Market Share by Region (2018-2023)
Table 13. Global Uterine Fibroids Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Uterine Fibroids Treatment Market Share by Region (2024-2033)
Table 15. Uterine Fibroids Treatment Market Trends
Table 16. Uterine Fibroids Treatment Market Drivers
Table 17. Uterine Fibroids Treatment Market Challenges
Table 18. Uterine Fibroids Treatment Market Restraints
Table 19. Global Uterine Fibroids Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Uterine Fibroids Treatment Market Share by Players (2018-2023)
Table 21. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Fibroids Treatment as of 2022)
Table 22. Ranking of Global Top Uterine Fibroids Treatment Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Uterine Fibroids Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Uterine Fibroids Treatment Product Solution and Service
Table 26. Date of Enter into Uterine Fibroids Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Uterine Fibroids Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Uterine Fibroids Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Uterine Fibroids Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Uterine Fibroids Treatment Revenue Market Share by Type (2024-2033)
Table 32. Global Uterine Fibroids Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Uterine Fibroids Treatment Revenue Market Share by Application (2018-2023)
Table 34. Global Uterine Fibroids Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Uterine Fibroids Treatment Revenue Market Share by Application (2024-2033)
Table 36. North America Uterine Fibroids Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Uterine Fibroids Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Uterine Fibroids Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Uterine Fibroids Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Uterine Fibroids Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Uterine Fibroids Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Uterine Fibroids Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Uterine Fibroids Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Uterine Fibroids Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Uterine Fibroids Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Uterine Fibroids Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 51. Blue Endo Company Detail
Table 52. Blue Endo Business Overview
Table 53. Blue Endo Uterine Fibroids Treatment Product
Table 54. Blue Endo Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 55. Blue Endo Recent Development
Table 56. Boston Scientific Corporation Company Detail
Table 57. Boston Scientific Corporation Business Overview
Table 58. Boston Scientific Corporation Uterine Fibroids Treatment Product
Table 59. Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 60. Boston Scientific Corporation Recent Development
Table 61. Cooper Surgical Company Detail
Table 62. Cooper Surgical Business Overview
Table 63. Cooper Surgical Uterine Fibroids Treatment Product
Table 64. Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 65. Cooper Surgical Recent Development
Table 66. Acessa Health, Inc. Company Detail
Table 67. Acessa Health, Inc. Business Overview
Table 68. Acessa Health, Inc. Uterine Fibroids Treatment Product
Table 69. Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 70. Acessa Health, Inc. Recent Development
Table 71. Karl Storz Company Detail
Table 72. Karl Storz Business Overview
Table 73. Karl Storz Uterine Fibroids Treatment Product
Table 74. Karl Storz Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 75. Karl Storz Recent Development
Table 76. LiNA Medical Company Detail
Table 77. LiNA Medical Business Overview
Table 78. LiNA Medical Uterine Fibroids Treatment Product
Table 79. LiNA Medical Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 80. LiNA Medical Recent Development
Table 81. Merit Medical Systems Company Detail
Table 82. Merit Medical Systems Business Overview
Table 83. Merit Medical Systems Uterine Fibroids Treatment Product
Table 84. Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 85. Merit Medical Systems Recent Development
Table 86. Olympus Corporation Company Detail
Table 87. Olympus Corporation Business Overview
Table 88. Olympus Corporation Uterine Fibroids Treatment Product
Table 89. Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2018-2023) & (US$ Million)
Table 90. Olympus Corporation Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Fibroids Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Uterine Fibroids Treatment Market Share by Type: 2022 VS 2033
Figure 3. Endometrial Ablation Features
Figure 4. MRI Guided Procedures Features
Figure 5. Hysterectomy Features
Figure 6. Myomectomy Features
Figure 7. Uterine Artery Embolization Features
Figure 8. Radiofrequency Ablation Features
Figure 9. Others Features
Figure 10. Global Uterine Fibroids Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Uterine Fibroids Treatment Market Share by Application: 2022 VS 2033
Figure 12. Hospitals Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Uterine Fibroids Treatment Report Years Considered
Figure 16. Global Uterine Fibroids Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Uterine Fibroids Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Uterine Fibroids Treatment Market Share by Region: 2022 VS 2033
Figure 19. Global Uterine Fibroids Treatment Market Share by Players in 2022
Figure 20. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Fibroids Treatment as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Uterine Fibroids Treatment Revenue in 2022
Figure 22. North America Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Uterine Fibroids Treatment Market Share by Country (2018-2033)
Figure 24. United States Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Uterine Fibroids Treatment Market Share by Country (2018-2033)
Figure 28. Germany Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Uterine Fibroids Treatment Market Share by Region (2018-2033)
Figure 36. China Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Uterine Fibroids Treatment Market Share by Country (2018-2033)
Figure 44. Mexico Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Uterine Fibroids Treatment Market Share by Country (2018-2033)
Figure 48. Turkey Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Uterine Fibroids Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Blue Endo Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 51. Boston Scientific Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 52. Cooper Surgical Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 53. Acessa Health, Inc. Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 54. Karl Storz Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 55. LiNA Medical Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 56. Merit Medical Systems Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 57. Olympus Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed